复发性与晚期宫颈癌全身治疗概述:放射科医生入门指南
本文综述复发性及晚期宫颈癌的典型与非典型横断面影像表现,并讨论近年可及的全身治疗方案及其相应影像学后遗表现;盆腔放疗普及使复发表现趋于不典型,而全身治疗药物(含免疫检查点抑制剂、生物类似药等)在中低收入国家也已可及。
要点
- 盆腔放疗普及后复发性宫颈癌的非典型影像表现增多,阅片需警惕。
- 盆腔复发可考虑局部区域治疗,远处转移则以全身治疗为标准治疗。
- 不同全身治疗方案各有特定的疗效反应模式与毒性影像后遗表现。
核心结论
- 影像在宫颈癌监测中居核心地位,指导复发启动治疗的时机及晚期管理。
- 不同全身治疗药物各具特定的反应模式与毒性,需在影像随访中识别其相应后遗表现。
研究设计与样本
- 综述类文章,检索范围与纳入文献原文未报告。
关键影像表现/征象
- 复发性宫颈癌可表现为盆腔复发,也可转移至胸腹部器官、淋巴结、骨、皮肤和脑。
- 盆腔放疗可及性增加使复发性疾病非典型表现的发生率上升。
临床应用与阅片要点
- 全身治疗是远处转移性复发性宫颈癌的标准治疗,盆腔复发可考虑局部区域治疗。
- 除联合化疗方案外,替代化疗、生物类似药和免疫检查点抑制剂均已可及,各自具有特定的反应与毒性模式。
- 阅片时应结合所用全身治疗药物,识别其相应的影像学后遗表现。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Imaging has a central role in surveillance of cervical cancer, guiding decision on when to initiate treatment for recurrent disease and to guide management in advanced cervical cancer. Due to the increased availability of pelvic radiation therapy, the rate of atypical presentation of recurrent disease has increased. Simultaneously, the array of systemic therapies now available for advanced cervical cancer has considerably expanded in the last few years, with therapies now available in mid and low-income countries. While pelvic recurrences are amenable of loco-regional treatment, recurrent disease may present with metastases to the thoracoabdominal organs, lymph nodes, bones, skin and brain, for which systemic treatment represent the standard of care. Besides combined chemotherapy regimens, alternative chemotherapies, biosimilars and immune checkpoint inhibitors are now available, each associated with a definite pattern of response and toxicity. In this review, after describing the typical and atypical presentations of recurrent and advanced cervical carcinoma on cross-sectional imaging, we will discuss systemic treatment for recurrent or advanced disease and their associated radiographic sequelae, in light of the newly available therapies.
引用
- Marshall C, Rajdev MA, Somarouthu B, et al. Overview of systemic treatment in recurrent and advanced cervical cancer: a primer for radiologists. Abdom Radiol (NY). 2019. PMID: 30288585. doi:10.1007/s00261-018-1797-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。